Biolyst › VALNCash & investments
EUR 110M
Valneva SE is tracked here for clinical trial milestones, SEC filings and earnings dates. Focus area: Biological Products, (No Diagnostic Substances).
No upcoming catalysts are currently on record for VALN. Past events are listed below.
Cash runway is approximately 13.4 months based on the most recent reported cash position and quarterly operating burn as of 2025-12-31.
Across 39 concluded trials, 90% reached completion rather than being terminated or withdrawn.
Upcoming catalysts
Nothing scheduled.
Track VALN alongside other companies. Add it to a watchlist and see every catalyst on one calendar.
Open VALN in the tracker
Recent history
Date Event Type Phase
October 8, 2026
6-K filed: Foreign issuer report Filing
—
August 14, 2026
6-K filed: Foreign issuer report Filing
—
August 13, 2026
6-K filed: Foreign issuer report Filing
—
July 22, 2026
6-K filed: Foreign issuer report Filing
—
June 25, 2026
6-K filed: Foreign issuer report Filing
—
June 5, 2026
6-K filed: Foreign issuer report Filing
—
June 1, 2026
6-K filed: Foreign issuer report Filing
—
May 13, 2026
6-K filed: Foreign issuer report Filing
—
May 5, 2026
6-K filed: Foreign issuer report Filing
—
April 30, 2026
6-K filed: Foreign issuer report Filing
—
March 26, 2026
6-K filed: Foreign issuer report Filing
—
March 23, 2026
6-K filed: Foreign issuer report Filing
—
March 18, 2026
6-K filed: Foreign issuer report Filing
—
March 17, 2026
Results filed (20-F) Earnings
—
March 9, 2026
6-K filed: Foreign issuer report Filing
—
March 2, 2026
6-K filed: Foreign issuer report Filing
—
February 19, 2026
6-K filed: Foreign issuer report Filing
—
February 13, 2026
6-K filed: Foreign issuer report Filing
—
February 3, 2026
6-K filed: Foreign issuer report Filing
—
January 20, 2026
6-K filed: Foreign issuer report Filing
—
January 9, 2026
6-K filed: Foreign issuer report Filing
—
December 31, 2025
6-K filed: Foreign issuer report Filing
—
December 11, 2025
6-K filed: Foreign issuer report Filing
—
November 28, 2025
6-K filed: Foreign issuer report Filing
—
November 26, 2025
6-K filed: Foreign issuer report Filing
—
November 20, 2025
6-K filed: Foreign issuer report Filing
—
November 4, 2025
6-K filed: Foreign issuer report Filing
—
October 6, 2025
6-K filed: Foreign issuer report Filing
—
October 6, 2025
6-K filed: Foreign issuer report Filing
—
October 6, 2025
6-K/A filed: Foreign issuer report Filing
—
About this data
Trial milestones come from the ClinicalTrials.gov v2 API, filings from SEC EDGAR, and financial figures from SEC XBRL company facts. Dates marked est. are projected rather than company-confirmed. This is an information tool, not investment advice — verify anything you act on against the linked primary source.
Last updated 2026-10-14.